Avinger to Announce Third Quarter 2024 Results on November 7, 2024
Avinger (NASDAQ:AVGR), a commercial-stage medical device company specializing in intravascular image-guided catheter-based systems, has scheduled its third quarter 2024 financial results announcement for November 7, 2024, after market close. The company will host a conference call at 1:30pm PT/4:30pm ET. Investors can join via telephone at +1-973-528-0011 using passcode 442577 or through a live webcast available on the company's investor relations webpage. A replay will be available on Avinger's website after the call.
Avinger (NASDAQ:AVGR), un'azienda medica in fase commerciale specializzata in sistemi a catetere guidati da immagini intravascolari, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per il 7 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conference call alle 1:30 PM PT/4:30 PM ET. Gli investitori possono partecipare telefonicamente al numero +1-973-528-0011 utilizzando il codice di accesso 442577 o tramite un webcast dal vivo disponibile sulla pagina delle relazioni con gli investitori dell'azienda. Una registrazione sarà disponibile sul sito web di Avinger dopo la chiamata.
Avinger (NASDAQ:AVGR), una empresa de dispositivos médicos en etapa comercial que se especializa en sistemas de catéteres guiados por imágenes intravasculares, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el 7 de noviembre de 2024, después del cierre del mercado. La compañía llevará a cabo una llamada de conferencia a la 1:30 PM PT/4:30 PM ET. Los inversores pueden unirse por teléfono al +1-973-528-0011 usando el código de acceso 442577 o a través de un webcast en vivo disponible en la página de relaciones con inversionistas de la empresa. Una reproducción estará disponible en el sitio web de Avinger después de la llamada.
Avinger (NASDAQ:AVGR)는 혈관 내 이미지를 기반으로 한 카테터 시스템을 전문으로 하는 상업 단계의 의료 기기 회사로, 2024년 3분기 재무 결과 발표를 2024년 11월 7일, 시장 종료 후로 예정하였습니다. 회사는 태평양 표준시 기준 오후 1시 30분/동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 진행합니다. 투자자들은 +1-973-528-0011로 전화에 접속하여 비밀번호 442577을 사용하거나 회사의 투자자 관계 웹페이지에서 제공되는 실시간 웹캐스트를 통해 참여할 수 있습니다. 콜 후에는 Avinger의 웹사이트에서 재방송을 이용할 수 있습니다.
Avinger (NASDAQ:AVGR), une entreprise de dispositifs médicaux à un stade commercial spécialisée dans les systèmes de cathéters guidés par des images intravasculaires, a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 pour le 7 novembre 2024, après la clôture des marchés. L'entreprise organisera une conférence téléphonique à 13h30 PT/16h30 ET. Les investisseurs peuvent se joindre par téléphone au +1-973-528-0011 en utilisant le code d'accès 442577 ou via un webinaire en direct disponible sur la page des relations avec les investisseurs de l'entreprise. Un replay sera disponible sur le site web d'Avinger après l'appel.
Avinger (NASDAQ:AVGR), ein Unternehmen für medizinische Geräte in der Kommerziellen Phase, das auf katheterbasierte Systeme mit intravaskulärer Bildführung spezialisiert ist, hat die Bekanntgabe seiner finanziellen Ergebnisse für das dritte Quartal 2024 für den 7. November 2024, nach Börsenschluss, angesetzt. Das Unternehmen wird um 13:30 Uhr PT/16:30 Uhr ET eine Telefonkonferenz abhalten. Investoren können sich telefonisch unter +1-973-528-0011 mit dem Zugangscode 442577 einwählen oder über ein Live-Webcast, das auf der Webseite für Investorenbeziehungen des Unternehmens verfügbar ist, teilnehmen. Eine Aufzeichnung wird nach dem Anruf auf der Website von Avinger verfügbar sein.
- None.
- None.
REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the third quarter 2024 after the close of trading on Thursday, November 7, 2024. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.
To join the call by telephone, please dial +1- 973-528-0011 and use passcode 442577. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.avinger.com.
A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.
About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first image-guided, catheter-based system for the diagnosis and treatment of patients with vascular disease in the peripheral and coronary arteries. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox series of imaging consoles, the Ocelot and Tigereye® family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices for the treatment of peripheral artery disease (PAD), estimated to affect more than 200 million people worldwide. Avinger is developing its first product application for the treatment of coronary artery disease (CAD), an image-guided system for CTO-crossing in the coronary arteries, which provides the opportunity to redefine a large and underserved market. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.
Follow Avinger on X and Facebook.
Investor Contact:
Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com
SOURCE: Avinger, Inc.
View the original press release on accesswire.com
FAQ
When will Avinger (AVGR) release Q3 2024 earnings?
What time is Avinger's (AVGR) Q3 2024 earnings call?
How can I access Avinger's (AVGR) Q3 2024 earnings call?
